Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 32 checked references that resolve
resolves10.1002/prot.10259Kinase inhibitors and the case for CH…O hydrogen bonds in protein–ligand binding
resolves10.1016/S0969-2126(97)00304-3Structures of staurosporine bound to CDK2 and cAPK – new tools for structure-based design of protein kinase inhibitors
resolves10.1016/S0969-2126(99)80086-0Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors
resolves10.1006/jmbi.1998.2369Structure of the protein tyrosine kinase domain of C-terminal Src kinase (CSK) in complex with staurosporine 1 1Edited by I. A. Wilson
resolves10.1042/bj20031119Structural basis for UCN-01 (7-hydroxystaurosporine) specificity and PDK1 (3-phosphoinositide-dependent protein kinase-1) inhibition
resolves10.1006/jmbi.1996.0189Three-dimensional Structure of Mammalian Casein Kinase I: Molecular Basis for Phosphate Recognition
resolves10.1016/S1093-3263(99)00015-7Molecular scaffold-based design and comparison of combinatorial libraries focused on the ATP-binding site of protein kinases
resolves10.1016/j.jmb.2003.12.056Molecular Determinants for ATP-binding in Proteins: A Data Mining and Quantum Chemical Analysis
resolves10.1021/jm960118j4-(Phenylamino)pyrrolopyrimidines: Potent and Selective, ATP Site Directed Inhibitors of the EGF-Receptor Protein Tyrosine Kinase
resolves10.1021/jm960789hTyrosine Kinase Inhibitors. 11. Soluble Analogues of Pyrrolo- and Pyrazoloquinazolines as Epidermal Growth Factor Receptor Inhibitors: Synthesis, Biological Evaluation, and Modeling of the Mode of Binding
resolves10.1021/jm020241cSynthesis and Structure−Activity Relationships of 6,7-Disubstituted 4-Anilinoquinoline-3-carbonitriles. The Design of an Orally Active, Irreversible Inhibitor of the Tyrosine Kinase Activity of the Epidermal Growth Factor Receptor (EGFR) and the Human Epidermal Growth Factor Receptor-2 (HER-2)
resolves10.1038/nsb770Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site
resolves10.1016/S1074-5521(98)90170-3Conversion of SB 203580-insensitive MAP kinase family members to drug-sensitive forms by a single amino-acid substitution
resolves10.1093/emboj/17.20.5896Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain
resolves10.1021/ja0264798Inhibitor Scaffolds as New Allele Specific Kinase Substrates
resolves10.1021/jm00050a010Molecular Similarity Indices in a Comparative Analysis (CoMSIA) of Drug Molecules to Correlate and Predict Their Biological Activity
resolves10.1023/A:1008047919606Comparative Molecular Similarity Index Analysis (CoMSIA) to study hydrogen-bonding properties and to score combinatorial libraries
resolves10.1021/jm981062rThree-Dimensional Quantitative Structure−Activity Relationship Analyses Using Comparative Molecular Field Analysis and Comparative Molecular Similarity Indices Analysis To Elucidate Selectivity Differences of Inhibitors Binding to Trypsin, Thrombin, and Factor Xa
resolves10.1021/ci0256586Chemometrical Classification of Ephrin Ligands and Eph Kinases Using GRID/CPCA Approach
resolves10.1021/jm0109053Structural Differences of Matrix Metalloproteinases with Potential Implications for Inhibitor Selectivity Examined by the GRID/CPCA Approach
resolves10.1021/jm000934yGRID/CPCA: A New Computational Tool To Design Selective Ligands
checked 2026-07-25 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.